Form 8-K MERIDIAN BIOSCIENCE INC For: Apr 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Meridian Bioscience (VIVO) Tops Q2 EPS by 3c
April 30, 2019 8:32 AM EDTMeridian Bioscience (NASDAQ: VIVO) reported Q2 EPS of $0.19, $0.03 better than the analyst estimate of $0.16. Revenue for the quarter came in at $50.2 million versus the consensus estimate of $51.74 million.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
... More
